Master
Credit
Heading
Featured News: A novel strategy to suppress prostate cancer growth
Content
Dr. Yang鈥檚 team took a close look into what drives the growth of advanced tumors that have become resistant to standard castration therapy. Working with cells in the lab and animal models, they discovered an approach that suppresses the growth of therapy-resistant tumors. View press release and .
Heading
Lab Related News
Content
- - Aug. 8, 2023
- A novel strategy to suppress triple negative breast cancer growth - Aug. 2, 2023
- - Dec. 28, 2022
- MAPK4, novel therapeutic target for triple-negative breast cancer - Jan. 11, 2022
- (From the Labs) - Dec. 6, 2021
- Targeting MAPK4: potential therapy for prostate cancer - Feb. 23, 2021
- Baylor researchers receive nearly $2.7 million in CPRIT grants - Feb. 13, 2020
Heading
Recent Studies
Content
Our most recent studies featured by the Department of Defense research programs demonstrate the impact and importance of our studies:
- Department of Defense/Breast Cancer Research Program (2023 news)
"" - Department of Defense/Breast Cancer Research Program (2022 news)
鈥溾 - Department of Defense/Prostate Cancer Research Program (2021 news)
鈥溾
